Literature DB >> 19019687

Synthesis and evaluation of electron-rich curcumin analogues.

Michael W Amolins1, Laura B Peterson, Brian S J Blagg.   

Abstract

The natural product curcumin has long been recognized for its medicinal properties and is utilized for the treatment of many diseases. However, it remains unknown whether this activity is based on its presumably promiscuous scaffold, or if it results from the Michael acceptor properties of the alpha,beta-unsaturated 1,3-diketone moiety central to its structure. To probe this issue, electron-rich pyrazole and isoxazole analogues were prepared and evaluated against two breast cancer cell lines, which resulted in the identification of several compounds that exhibit low micromolar to mid nanomolar anti-proliferative activity. A conjugate addition study was also performed to compare the relative electrophilicity of the diketone, pyrazole and isoxazole analogues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019687      PMCID: PMC2753864          DOI: 10.1016/j.bmc.2008.10.057

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  21 in total

1.  Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.

Authors:  Hironori Ohtsu; Zhiyan Xiao; Junko Ishida; Masahiro Nagai; Hui-Kang Wang; Hideji Itokawa; Ching-Yuan Su; Charles Shih; Tzuying Chiang; Eugene Chang; YiFen Lee; Meng-Yin Tsai; Chawnshang Chang; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2002-11-07       Impact factor: 7.446

2.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Authors:  A L Cheng; C H Hsu; J K Lin; M M Hsu; Y F Ho; T S Shen; J Y Ko; J T Lin; B R Lin; W Ming-Shiang; H S Yu; S H Jee; G S Chen; T M Chen; C A Chen; M K Lai; Y S Pu; M H Pan; Y J Wang; C C Tsai; C Y Hsieh
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

3.  Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo.

Authors:  Erl-Shyh Kao; Chau-Jong Wang; Wea-Lung Lin; Yu-Fang Yin; Chi-Pin Wang; Tsui-Hwa Tseng
Journal:  J Agric Food Chem       Date:  2005-01-26       Impact factor: 5.279

Review 4.  Pharmacology of Curcuma longa.

Authors:  H P Ammon; M A Wahl
Journal:  Planta Med       Date:  1991-02       Impact factor: 3.352

5.  Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents.

Authors:  C Selvam; Sanjay M Jachak; Ramasamy Thilagavathi; Asit K Chakraborti
Journal:  Bioorg Med Chem Lett       Date:  2005-04-01       Impact factor: 2.823

6.  In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties.

Authors:  M M Chan; H I Huang; M R Fenton; D Fong
Journal:  Biochem Pharmacol       Date:  1998-06-15       Impact factor: 5.858

Review 7.  Biological properties of curcumin-cellular and molecular mechanisms of action.

Authors:  B Joe; M Vijaykumar; B R Lokesh
Journal:  Crit Rev Food Sci Nutr       Date:  2004       Impact factor: 11.176

8.  Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.

Authors:  G Shoba; D Joy; T Joseph; M Majeed; R Rajendran; P S Srinivas
Journal:  Planta Med       Date:  1998-05       Impact factor: 3.352

9.  Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases.

Authors:  R Rashmi; T R Santhosh Kumar; D Karunagaran
Journal:  FEBS Lett       Date:  2003-03-13       Impact factor: 4.124

10.  Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease.

Authors:  So-Young Park; Darrick S H L Kim
Journal:  J Nat Prod       Date:  2002-09       Impact factor: 4.050

View more
  18 in total

Review 1.  Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Subhash Padhye
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

2.  Design and synthesis of novel iminothiazinylbutadienols and divinylpyrimidinethiones as ARE inducers.

Authors:  Lin Chen; Sadagopan Magesh; Hong Wang; Chung S Yang; Ah-Ng Tony Kong; Longqin Hu
Journal:  Bioorg Med Chem Lett       Date:  2013-12-24       Impact factor: 2.823

Review 3.  Degradation of Curcumin: From Mechanism to Biological Implications.

Authors:  Claus Schneider; Odaine N Gordon; Rebecca L Edwards; Paula B Luis
Journal:  J Agric Food Chem       Date:  2015-04-02       Impact factor: 5.279

4.  Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.

Authors:  Li Lin; Brian Hutzen; Mingxin Zuo; Sarah Ball; Stephanie Deangelis; Elizabeth Foust; Bulbul Pandit; Michael A Ihnat; Satyendra S Shenoy; Samuel Kulp; Pui-Kai Li; Chenglong Li; James Fuchs; Jiayuh Lin
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

5.  KSRP/FUBP2 Is a Binding Protein of GO-Y086, a Cytotoxic Curcumin Analogue.

Authors:  Hiroyuki Yamakoshi; Naoki Kanoh; Chieko Kudo; Atsuko Sato; Kazunori Ueda; Makoto Muroi; Shunsuke Kon; Masanobu Satake; Hisatsugu Ohori; Chikashi Ishioka; Yoshiteru Oshima; Hiroyuki Osada; Natsuko Chiba; Hiroyuki Shibata; Yoshiharu Iwabuchi
Journal:  ACS Med Chem Lett       Date:  2010-06-04       Impact factor: 4.345

Review 6.  Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry.

Authors:  Subhash Padhye; Deepak Chavan; Shubhangini Pandey; Jyoti Deshpande; K Venkateswara Swamy; Fazlul H Sarkar
Journal:  Mini Rev Med Chem       Date:  2010-05       Impact factor: 3.862

7.  Synthesis and antibacterial activity of novel curcumin derivatives containing heterocyclic moiety.

Authors:  Othman A Hamed; Noha Mehdawi; Adham Abu Taha; Emad M Hamed; Mohammed A Al-Nuri; Ayman S Hussein
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 8.  Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?

Authors:  Anuj Khandelwal; Vincent M Crowley; Brian S J Blagg
Journal:  Med Res Rev       Date:  2015-05-25       Impact factor: 12.944

Review 9.  Perspectives on new synthetic curcumin analogs and their potential anticancer properties.

Authors:  Alok Vyas; Prasad Dandawate; Subhash Padhye; Aamir Ahmad; Fazlul Sarkar
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Modulation of protein quality control systems by food phytochemicals.

Authors:  Akira Murakami
Journal:  J Clin Biochem Nutr       Date:  2013-03-20       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.